Substituted biphenyl sulfonamide endothelin antagonists

Details Substituted biphenyl sulfonamide endothelin antagonists Substituted biphenyl sulfonamide endothelin antagonists

1996-07-25

1998-07-14

Gupta, Yogendra N.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514255, 514256, 514269, 514272, 514274, 514340, 514345, 514348, 514349, 514351, 514352, 514357, 544238, 544405, 544297, 544298, 544310, 544316, 544317, 544319, 544321, 544322, 544324, 544327, 544331, 544333, 5462721, A61K 31525, A61K 31505, C07D40500, C07D40900

Patent

active

057804737

ABSTRACT:
Compounds of the formula ##STR1## inhibit the activity of endothelin.

REFERENCES:
patent: 2888455 (1959-05-01), Kano et al.
patent: 5236928 (1993-08-01), Chakravarty et al.
patent: 5270313 (1993-12-01), Burri et al.
patent: 5292740 (1994-03-01), Burri et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5464853 (1995-11-01), Chan et al.
patent: 5571821 (1996-11-01), Chan et al.
patent: 5591761 (1997-01-01), Chan et al.
patent: 5594021 (1997-01-01), Chan et al.
patent: 5612359 (1997-03-01), Murugesan
S. Norio et al., Chemical Abstracts, vol. 70, No. 19, (1969), 87639g.
T. Saito, Chemical Abstracts, vol. 73, No. 23 (1970), 120511w.
Derwent Abstract No. 88-289069/41, Feb. 27, 1987.
Derwent Abstract No. 88-195835/28, Nov. 26, 1986.
Derwent Abstract No. 88-061295/09, Jul. 9, 1986.
Derwent Abstract No. 87-152485/22, Oct. 11, 1985.
Derwent Abstract No. 62299 E/30, Dec. 11, 1980.
Derwent Abstract No. 40927 D/23, Sep. 11, 1979.
Derwent Abstract No. 91-254550/35, Feb. 19, 1990.
Derwent Abstract No. 86-246709/38, Nov. 27, 1985.
Derwent Abstract No. 35012 K/15, Sep. 24, 1981.
Allen et al., "Preparation . . . antagonists", CA116(11):106284Z, p. 778, 1992.
Chan et al., "Identification of a New Class of ET.sub.A Selective Endothelin Antagonists by Pharmacophore Directed Screening", Biochemical and Biophysical Research Communications, vol. 201, No. 1, May 30, 1994, pp. 228-234.
Doherty, J. Med. Chem., 35(9), 1493-1508 (May 1992).
CA 65: 2241d (1966).
CA 92:41908v (1979).
Wang et al., "Nitrile . . . sinomin," CA 108:94444w, p. 651 (1988).
Khanna, "Oral . . . formulation," CA 115:35728p, p. 415 (1991).
Stein et al., "The Discovery . . . 1-naphthalenesulfonamide," CA 120:18233n, pp. 21-22 (1994).
Vree et al., "Renal excretion . . . function," CA 97:84685r, p. 23 (1982).
Oie, "Pharmacokinetics . . . dosing," CA102:1917512x, p. 18 (1985).
Murugesan et al., "N-(heteroaryl) . . . antagonists," CA 120:270370c, p. 1067 (1994).

Affiliated with

Also associated with

Rating

Substituted biphenyl sulfonamide endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted biphenyl sulfonamide endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted biphenyl sulfonamide endothelin antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1882015